Skip to content

百济神州

US · ONC #538 按市值排名 上市于 2016
369.06 -5.02 -1.34%
实时 - 追踪5344个代码 - 心跳于384秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

增持
  • 最近一期（2026/Q3）披露持股的机构数量减少了3家。
  • 机构持股总比例上升了2.0个百分点。

机构持股

机构持股比例
78.03% +2.00pp
机构数量
583 -3
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund42.06%
Public Company17.62%
Hedge Fund10.69%
VC/PE Fund5.08%
Individual/Insider4.10%
Sovereign Wealth Fund1.12%
Private Company0.95%
Government Pension Fund0.40%
Other17.89%

主要股东 截至 2025-12-31

Amgen Inc. 16.66% · 18.94M 股
Capital Research 8.43% · 9.58M 股
Baker Bros. Advisors LP 7.77% · 8.84M 股
PRIMECAP Management Company 4.41% · 5.01M 股
Hillhouse Capital Management, Ltd. 3.73% · 4.24M 股
John Oyler 3.12% · 3.54M 股
BlackRock 2.83% · 3.21M 股
China Asset Management Co., Ltd. 2.62% · 2.98M 股
Vanguard Capital Management, LLC 2.37% · 2.69M 股
FMR 2.16% · 2.45M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 16次买入 · 32次卖出

姓名职务持股比例
Amgen Inc. -- 16.66%
John Oyler Chairperson & CEO 3.12%
Xiaodong Wang Co- Chairman of Scientific Advisory Board & Non-Executive Director Co-Founder 0.63%
Wang Lai Global Head of R&D 0.15%
Xiaobin Wu President 0.05%
Chan Lee General Counsel & Senior VP 0.02%
Felix Baker Non-Executive Director 0.02%
Ranjeev Krishana Lead Independent Director 0.02%
Michael Goller Independent Non-Executive Director & Member of the Scientific Advisory Committee 0.02%
Julia A. Wang Chief Financial Officer 0.01%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-10-12 Xiaodong Wang Co-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder Derivative Exercise and Sale -31,027 $36.90–353.24
2026-09-29 Chan Lee General Counsel, Senior VP & Corporate Secretary Automatic Disposition -1,115 $375.00
2026-09-27 Xiaodong Wang Co-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder Derivative Exercise and Sale -31,028 $36.90–367.23
2026-09-07 Xiaodong Wang Co-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder Automatic Disposition -7,260 $345.38–348.01
2026-09-07 Xiaodong Wang Co-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder Derivative Exercise and Sale -31,027 $36.90–351.25
2026-08-31 Titus Ball Vice President Open Market Disposition -132 $355.86
2026-08-24 Corazon Sanders Former Independent Non-Executive Director Intent to Sell (Form 144) -2,075 $380.00
2026-08-24 Xiaobin Wu Former President Automatic Disposition -280 $380.00
2026-08-11 John Oyler Chairperson & CEO Automatic Disposition -240,810 $350.00–367.00
2026-08-10 Chan Lee General Counsel, Senior VP & Corporate Secretary Derivative Exercise and Sale -2,666 $159.03–360.00
2026-08-09 John Oyler Chairperson & CEO Intent to Sell (Form 144) -240,810 $348.27
2026-08-02 Aaron Rosenberg Chief Financial Officer Open Market Disposition -1,157 $312.72
2026-07-29 Chan Lee General Counsel, Senior VP & Corporate Secretary Open Market Disposition -1,044 $323.69
2026-07-21 Chan Lee General Counsel, Senior VP & Corporate Secretary Derivative Exercise and Sale -1,669 $159.03–325.00
2026-07-20 John Oyler Chairperson & CEO Automatic Disposition -75,723 $310.08–320.06
2026-07-19 John Oyler Chairperson & CEO Derivative Exercise and Sale -33,990 $119.96–318.30
2026-07-13 John Oyler Chairperson & CEO Automatic Disposition -12,261 $303.07–303.93
2026-07-09 John Oyler Chairperson & CEO Intent to Sell (Form 144) -150,000 $302.83
2026-07-07 Chan Lee General Counsel, Senior VP & Corporate Secretary Derivative Exercise and Sale -664 $159.03–302.46
2026-06-22 John Oyler Chairperson & CEO Open Market Disposition -3,410 $273.30–275.10

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

百济神州 讨论区 0 条评论

发表评论